On Jan 31st, Infex Therapeutics held a live webinar, to update on progress with our lead Phase II asset, RESP-X.
To view the webinar recording, please click on the link below:
Webinar on Infex's Phase II lead respiratory drug, RESP-X
February 6, 2024